PUBLIC CONTRACT · 2017
Agalsidase beta 35 mg pó sol inj fr IV
- Contract value
- €21,273.60
- Signed on
- 8 August 2017
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 3583742PUBLISHED SUBJECT
AGALSIDASE BETA 35 MG PÓ SOL INJ FR IV - Ajuste Directo No 14184317
Parties involved
- Place of performance
- Portugal, Setúbal, Almada
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- SANOFI - PRODUTOS FARMACÊUTICOS, LDA. · Tax ID 500134960
Values and timeline
- Contract price
- €21,273.60
- Procedure base price
- €21,273.60
- Total effective price
- Not reported on Portal BASE
- Publication date
- 9 August 2017
- Award date
- 25 July 2017
- Signing date
- 8 August 2017
- Performance period
- 180 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2869209
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.